nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—Nicergoline—ADRA1A—polycystic ovary syndrome	0.0123	0.281	CrCbGaD
Methysergide—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0114	0.117	CcSEcCtD
Methysergide—Heartburn—Metformin—polycystic ovary syndrome	0.00975	0.1	CcSEcCtD
Methysergide—Lightheadedness—Metformin—polycystic ovary syndrome	0.006	0.0617	CcSEcCtD
Methysergide—Pain in extremity—Metformin—polycystic ovary syndrome	0.00487	0.05	CcSEcCtD
Methysergide—Lisuride—ADRA1D—polycystic ovary syndrome	0.00424	0.097	CrCbGaD
Methysergide—Ergonovine—ADRA1A—polycystic ovary syndrome	0.00415	0.095	CrCbGaD
Methysergide—Ergotamine—ADRA1D—polycystic ovary syndrome	0.00407	0.0932	CrCbGaD
Methysergide—Neutropenia—Metformin—polycystic ovary syndrome	0.00394	0.0404	CcSEcCtD
Methysergide—Bromocriptine—ADRA1D—polycystic ovary syndrome	0.00392	0.0899	CrCbGaD
Methysergide—HTR2A—urine—polycystic ovary syndrome	0.00379	0.1	CbGeAlD
Methysergide—Drowsiness—Metformin—polycystic ovary syndrome	0.00375	0.0386	CcSEcCtD
Methysergide—Lisuride—ADRA1B—polycystic ovary syndrome	0.00361	0.0828	CrCbGaD
Methysergide—Ergotamine—ADRA1B—polycystic ovary syndrome	0.00347	0.0795	CrCbGaD
Methysergide—Bromocriptine—ADRA1B—polycystic ovary syndrome	0.00335	0.0767	CrCbGaD
Methysergide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00332	0.0341	CcSEcCtD
Methysergide—Flushing—Metformin—polycystic ovary syndrome	0.00313	0.0321	CcSEcCtD
Methysergide—HTR1E—female gonad—polycystic ovary syndrome	0.00297	0.0785	CbGeAlD
Methysergide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00272	0.028	CcSEcCtD
Methysergide—Malaise—Metformin—polycystic ovary syndrome	0.00265	0.0272	CcSEcCtD
Methysergide—Chest pain—Metformin—polycystic ovary syndrome	0.0025	0.0257	CcSEcCtD
Methysergide—Myalgia—Metformin—polycystic ovary syndrome	0.0025	0.0257	CcSEcCtD
Methysergide—Discomfort—Metformin—polycystic ovary syndrome	0.00247	0.0253	CcSEcCtD
Methysergide—Oedema—Metformin—polycystic ovary syndrome	0.00239	0.0246	CcSEcCtD
Methysergide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00234	0.0241	CcSEcCtD
Methysergide—Ergotamine—ADRA1A—polycystic ovary syndrome	0.00234	0.0535	CrCbGaD
Methysergide—Bromocriptine—ADRA1A—polycystic ovary syndrome	0.00225	0.0516	CrCbGaD
Methysergide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00218	0.0224	CcSEcCtD
Methysergide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00215	0.0221	CcSEcCtD
Methysergide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00213	0.0219	CcSEcCtD
Methysergide—Somnolence—Metformin—polycystic ovary syndrome	0.00213	0.0219	CcSEcCtD
Methysergide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00211	0.0217	CcSEcCtD
Methysergide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00207	0.0212	CcSEcCtD
Methysergide—Fatigue—Metformin—polycystic ovary syndrome	0.00206	0.0212	CcSEcCtD
Methysergide—Constipation—Metformin—polycystic ovary syndrome	0.00205	0.021	CcSEcCtD
Methysergide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00197	0.0203	CcSEcCtD
Methysergide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00196	0.0201	CcSEcCtD
Methysergide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00189	0.0194	CcSEcCtD
Methysergide—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.00188	0.0498	CbGeAlD
Methysergide—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00188	0.0497	CbGeAlD
Methysergide—Asthenia—Metformin—polycystic ovary syndrome	0.00172	0.0176	CcSEcCtD
Methysergide—SIGMAR1—endometrium—polycystic ovary syndrome	0.00168	0.0445	CbGeAlD
Methysergide—HTR2B—endometrium—polycystic ovary syndrome	0.00168	0.0444	CbGeAlD
Methysergide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00164	0.0168	CcSEcCtD
Methysergide—Dizziness—Metformin—polycystic ovary syndrome	0.00158	0.0163	CcSEcCtD
Methysergide—SIGMAR1—uterus—polycystic ovary syndrome	0.00155	0.041	CbGeAlD
Methysergide—HTR2B—uterus—polycystic ovary syndrome	0.00155	0.0409	CbGeAlD
Methysergide—Vomiting—Metformin—polycystic ovary syndrome	0.00152	0.0156	CcSEcCtD
Methysergide—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.00152	0.0402	CbGeAlD
Methysergide—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.00152	0.0401	CbGeAlD
Methysergide—HTR2B—adipose tissue—polycystic ovary syndrome	0.00151	0.04	CbGeAlD
Methysergide—Rash—Metformin—polycystic ovary syndrome	0.00151	0.0155	CcSEcCtD
Methysergide—Dermatitis—Metformin—polycystic ovary syndrome	0.00151	0.0155	CcSEcCtD
Methysergide—Nausea—Metformin—polycystic ovary syndrome	0.00142	0.0146	CcSEcCtD
Methysergide—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.00136	0.0359	CbGeAlD
Methysergide—HTR2B—adrenal gland—polycystic ovary syndrome	0.00136	0.0359	CbGeAlD
Methysergide—HTR1B—endocrine gland—polycystic ovary syndrome	0.00131	0.0345	CbGeAlD
Methysergide—SIGMAR1—female gonad—polycystic ovary syndrome	0.00127	0.0335	CbGeAlD
Methysergide—SIGMAR1—vagina—polycystic ovary syndrome	0.00126	0.0333	CbGeAlD
Methysergide—HTR2B—vagina—polycystic ovary syndrome	0.00126	0.0332	CbGeAlD
Methysergide—HTR2A—embryo—polycystic ovary syndrome	0.00122	0.0324	CbGeAlD
Methysergide—HTR1A—adrenal gland—polycystic ovary syndrome	0.00122	0.0321	CbGeAlD
Methysergide—HTR7—adrenal gland—polycystic ovary syndrome	0.00116	0.0307	CbGeAlD
Methysergide—HTR1A—endocrine gland—polycystic ovary syndrome	0.00105	0.0279	CbGeAlD
Methysergide—HTR7—endocrine gland—polycystic ovary syndrome	0.00101	0.0266	CbGeAlD
Methysergide—HTR2A—pituitary gland—polycystic ovary syndrome	0.000811	0.0214	CbGeAlD
Methysergide—HTR2A—adrenal gland—polycystic ovary syndrome	0.000724	0.0191	CbGeAlD
Methysergide—HTR2A—vagina—polycystic ovary syndrome	0.000671	0.0177	CbGeAlD
Methysergide—HTR2A—endocrine gland—polycystic ovary syndrome	0.000628	0.0166	CbGeAlD
Methysergide—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	7.92e-05	9.65e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	7.88e-05	9.6e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	7.88e-05	9.6e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	7.88e-05	9.6e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	7.86e-05	9.57e-05	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	7.85e-05	9.56e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.82e-05	9.52e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.81e-05	9.51e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.8e-05	9.5e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.76e-05	9.45e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.76e-05	9.45e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IRS2—polycystic ovary syndrome	7.74e-05	9.43e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ATF1—polycystic ovary syndrome	7.74e-05	9.43e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ATF1—polycystic ovary syndrome	7.73e-05	9.42e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ATF1—polycystic ovary syndrome	7.68e-05	9.35e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	7.68e-05	9.35e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.6e-05	9.25e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—LEP—polycystic ovary syndrome	7.57e-05	9.22e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.55e-05	9.19e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.54e-05	9.18e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	7.52e-05	9.16e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.51e-05	9.15e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.5e-05	9.14e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.49e-05	9.12e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.46e-05	9.08e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.44e-05	9.06e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	7.42e-05	9.04e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GHRL—polycystic ovary syndrome	7.41e-05	9.02e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PLAT—polycystic ovary syndrome	7.41e-05	9.02e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	7.4e-05	9.01e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	7.36e-05	8.97e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	7.36e-05	8.96e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.33e-05	8.93e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IRS2—polycystic ovary syndrome	7.3e-05	8.89e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.3e-05	8.89e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	7.3e-05	8.89e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	7.27e-05	8.85e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	7.26e-05	8.84e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—LEP—polycystic ovary syndrome	7.15e-05	8.7e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NGFR—polycystic ovary syndrome	7.14e-05	8.7e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NGFR—polycystic ovary syndrome	7.14e-05	8.69e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.13e-05	8.69e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—POMC—polycystic ovary syndrome	7.1e-05	8.64e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—POMC—polycystic ovary syndrome	7.09e-05	8.63e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NGFR—polycystic ovary syndrome	7.09e-05	8.63e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PRL—polycystic ovary syndrome	7.08e-05	8.62e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PRL—polycystic ovary syndrome	7.07e-05	8.61e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ATF1—polycystic ovary syndrome	7.07e-05	8.6e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—POMC—polycystic ovary syndrome	7.04e-05	8.58e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PRL—polycystic ovary syndrome	7.03e-05	8.56e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.03e-05	8.56e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	6.98e-05	8.5e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	6.94e-05	8.45e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	6.94e-05	8.45e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	6.9e-05	8.41e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	6.9e-05	8.4e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.89e-05	8.39e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	6.88e-05	8.38e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.86e-05	8.35e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	6.85e-05	8.34e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.82e-05	8.31e-05	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	6.82e-05	8.3e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.82e-05	8.3e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.77e-05	8.25e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IRS1—polycystic ovary syndrome	6.76e-05	8.23e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	6.74e-05	8.21e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.72e-05	8.18e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.71e-05	8.17e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.66e-05	8.12e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.63e-05	8.07e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.63e-05	8.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.6e-05	8.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.53e-05	7.95e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.53e-05	7.95e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NGFR—polycystic ovary syndrome	6.52e-05	7.94e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—POMC—polycystic ovary syndrome	6.51e-05	7.92e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.49e-05	7.91e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—POMC—polycystic ovary syndrome	6.48e-05	7.89e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—INS—polycystic ovary syndrome	6.47e-05	7.88e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PRL—polycystic ovary syndrome	6.46e-05	7.87e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	6.46e-05	7.87e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	6.43e-05	7.83e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	6.39e-05	7.78e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IRS1—polycystic ovary syndrome	6.37e-05	7.76e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	6.3e-05	7.68e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF1—polycystic ovary syndrome	6.26e-05	7.62e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKT2—polycystic ovary syndrome	6.25e-05	7.62e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.23e-05	7.58e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GNAS—polycystic ovary syndrome	6.23e-05	7.58e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GNAS—polycystic ovary syndrome	6.22e-05	7.58e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GNAS—polycystic ovary syndrome	6.18e-05	7.53e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—POMC—polycystic ovary syndrome	6.14e-05	7.48e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.13e-05	7.47e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—INS—polycystic ovary syndrome	6.1e-05	7.43e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	6.05e-05	7.37e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	6.03e-05	7.34e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	6.01e-05	7.31e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	6.01e-05	7.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	5.98e-05	7.28e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	5.98e-05	7.28e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.94e-05	7.24e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.93e-05	7.22e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.93e-05	7.22e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1—polycystic ovary syndrome	5.9e-05	7.19e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKT2—polycystic ovary syndrome	5.9e-05	7.19e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.89e-05	7.17e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NRG1—polycystic ovary syndrome	5.82e-05	7.09e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NRG1—polycystic ovary syndrome	5.82e-05	7.08e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.79e-05	7.05e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NRG1—polycystic ovary syndrome	5.78e-05	7.04e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.76e-05	7.02e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.76e-05	7.01e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.73e-05	6.98e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.73e-05	6.97e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	5.7e-05	6.94e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.68e-05	6.92e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.66e-05	6.89e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.64e-05	6.87e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.61e-05	6.83e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.59e-05	6.8e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	5.58e-05	6.8e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.56e-05	6.77e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.56e-05	6.77e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.53e-05	6.74e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.42e-05	6.59e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.32e-05	6.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.29e-05	6.44e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	5.26e-05	6.41e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.25e-05	6.4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	5.24e-05	6.38e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	5.23e-05	6.37e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	5.21e-05	6.35e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.19e-05	6.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.19e-05	6.32e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.05e-05	6.15e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.02e-05	6.12e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5e-05	6.09e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IRS2—polycystic ovary syndrome	4.99e-05	6.07e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IRS2—polycystic ovary syndrome	4.98e-05	6.07e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.97e-05	6.05e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	4.95e-05	6.03e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	4.95e-05	6.03e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.95e-05	6.02e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—LEP—polycystic ovary syndrome	4.88e-05	5.94e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—LEP—polycystic ovary syndrome	4.88e-05	5.94e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.85e-05	5.9e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	4.84e-05	5.9e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.83e-05	5.88e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.8e-05	5.85e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—polycystic ovary syndrome	4.79e-05	5.83e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.74e-05	5.78e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.61e-05	5.61e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	4.59e-05	5.58e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	4.57e-05	5.56e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.55e-05	5.54e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	4.54e-05	5.53e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	4.53e-05	5.51e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—polycystic ovary syndrome	4.52e-05	5.5e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.46e-05	5.43e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.39e-05	5.35e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.37e-05	5.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.36e-05	5.31e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IRS1—polycystic ovary syndrome	4.35e-05	5.3e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IRS1—polycystic ovary syndrome	4.35e-05	5.3e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.32e-05	5.26e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.31e-05	5.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.29e-05	5.23e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.29e-05	5.22e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.23e-05	5.15e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—polycystic ovary syndrome	4.19e-05	5.11e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—polycystic ovary syndrome	4.19e-05	5.1e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—INS—polycystic ovary syndrome	4.17e-05	5.08e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—INS—polycystic ovary syndrome	4.17e-05	5.07e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.16e-05	5.07e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	4.14e-05	5.04e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.09e-05	4.98e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	4.07e-05	4.96e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	4.05e-05	4.93e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1—polycystic ovary syndrome	4.03e-05	4.91e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKT2—polycystic ovary syndrome	4.03e-05	4.91e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1—polycystic ovary syndrome	4.03e-05	4.91e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKT2—polycystic ovary syndrome	4.03e-05	4.9e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4e-05	4.87e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4e-05	4.87e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	3.98e-05	4.85e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.97e-05	4.84e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.92e-05	4.77e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.92e-05	4.77e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.86e-05	4.7e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.83e-05	4.66e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.83e-05	4.66e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.83e-05	4.66e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	3.81e-05	4.64e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.8e-05	4.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.79e-05	4.62e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.72e-05	4.53e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.72e-05	4.53e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.69e-05	4.5e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.68e-05	4.48e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.68e-05	4.48e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	3.67e-05	4.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.61e-05	4.4e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	3.59e-05	4.38e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.5e-05	4.26e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.22e-05	3.93e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.21e-05	3.9e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.19e-05	3.88e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.12e-05	3.8e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.1e-05	3.78e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.09e-05	3.76e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	3.09e-05	3.76e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	3.08e-05	3.76e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—polycystic ovary syndrome	3.08e-05	3.75e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.07e-05	3.74e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.06e-05	3.73e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	3e-05	3.65e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.99e-05	3.64e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.98e-05	3.63e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.97e-05	3.62e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.97e-05	3.61e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.84e-05	3.45e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—polycystic ovary syndrome	2.83e-05	3.44e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.82e-05	3.43e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.82e-05	3.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.78e-05	3.39e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.68e-05	3.27e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—polycystic ovary syndrome	2.67e-05	3.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.67e-05	3.25e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.63e-05	3.21e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.63e-05	3.2e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.61e-05	3.18e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.58e-05	3.14e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.58e-05	3.14e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.56e-05	3.12e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.45e-05	2.98e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.4e-05	2.93e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.28e-05	2.78e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.27e-05	2.77e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.97e-05	2.4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.95e-05	2.37e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.94e-05	2.36e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-05	2.22e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-05	2.22e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.81e-05	2.2e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.77e-05	2.16e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.68e-05	2.05e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.66e-05	2.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.35e-05	1.64e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-05	1.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.17e-05	1.42e-05	CbGpPWpGaD
